1. US Department of Health and Human Services, US Food and Drug Administration. Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development. http://www.fda.gov/downloads/scienceresearch/specialtopics/personalizedmedicine/ucm372421.pdf. Accessed November 1, 2013.
2. FDA Investigational Device Exemption (IDE) Approval Process website. http://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/investigationaldeviceexemptionide/ucm046164.htm. Accessed April 20, 2014.
3. Philip R. Personalized medicine and companion diagnostics. Presented at: Drug Information Association (DIA) Meeting on Personalized Medicine and Companion Diagnostics; Alexandria, VA; November 2013.
4. Use of “-omics” technologies in the development of personalised medicine. European Commission Report. October 25, 2013. http://ec.europa.eu/health/files/latest_news/2013-10_personalised_medicine_en.pdf. Accessed April 19, 2014.
5. Zineh I, Woodcock J. Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation. Clin Pharmacol Ther. 2013;93 (6):515–525.